معرفی
Mila Welling is a researcher in the Department of Pediatrics at Erasmus MC, Rotterdam, focusing on genetic and metabolic causes of obesity. Her work bridges clinical pediatrics and molecular endocrinology, with a strong emphasis on personalized treatment strategies for patients with defects in the leptin-melanocortin pathway.
Her research interests include:
- Genetic obesity syndromes, particularly MC4R deficiency
- Pharmacological interventions such as setmelanotide, liraglutide, and naltrexone-bupropion
- Diagnostic approaches for monogenic obesity
- Longitudinal growth and neurodevelopmental patterns in obese pediatric populations
- Real-world effectiveness of antiobesity drugs
- Cellular signaling mechanisms in melanocortin receptors
The analysis of her recent publications reveals a consistent focus on translating genetic insights into clinical practice. Her studies span from basic science investigations of receptor function to large-scale clinical reviews and real-world observational data, demonstrating a multidisciplinary approach that integrates molecular biology, pharmacology, and patient-centered outcomes. A significant trend is the evaluation of novel and repurposed pharmacotherapies for rare obesity disorders, aiming to improve both metabolic parameters and quality of life.
She has contributed to high-impact journals such as Endocrine Reviews, Obesity, and EClinicalMedicine, often collaborating with leading experts in endocrinology and pediatric metabolism. Notably, her 2025 review in Endocrine Reviews provides a comprehensive framework for antiobesity pharmacotherapy in genetically defined patients, positioning her as an emerging authority in this niche.
There are no listed scientific awards in the provided data.
Mila Welling completed her doctoral thesis titled Diagnostics and personalized treatment of genetic obesity in January 2025, indicating she is a recent PhD graduate. While no formal students are listed under her supervision, her role as a primary contributor to multiple peer-reviewed studies suggests active involvement in research mentorship and collaborative science. There is no mention of independent grant funding, though her participation in multi-author studies implies involvement in larger funded projects.
She is actively engaged in research within the pediatric endocrinology group at Erasmus MC, working closely with senior researchers including Prof. Eric F.C. van Rossum and Dr. Elise L.T. van den Akker. Her work appears to be integrated into a broader network studying obesity genetics and treatment, likely part of a dedicated research team or laboratory focused on metabolic diseases in children.
